title: Toxicity of antiretroviral agents.
authors.affiliation: U.S. Food and Drug Administration, Rockville, Maryland 20857, USA.
authors.forename: K A
authors.initials: KA
authors.lastname: Struble
authors.forename: R D
authors.initials: RD
authors.lastname: Pratt
authors.forename: S R
authors.initials: SR
authors.lastname: Gitterman
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D016049:Didanosine / Q000009:adverse effects; D015658:HIV Infections / Q000209:etiology / Q000517:prevention & control*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006282:Health Personnel; D006801:Humans; D019469:Indinavir / Q000009:adverse effects; D019259:Lamivudine / Q000009:adverse effects; D016273:Occupational Exposure / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects; D019438:Ritonavir / Q000009:adverse effects; D019258:Saquinavir / Q000009:adverse effects; D018119:Stavudine / Q000009:adverse effects; D016047:Zalcitabine / Q000009:adverse effects; D015215:Zidovudine / Q000009:adverse effects
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir; D016047:Zalcitabine; D018119:Stavudine; D016049:Didanosine; D019258:Saquinavir; D019438:Ritonavir